Literature DB >> 9343244

Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centers.

D R Anderson1, C M Carthy, J E Wilson, D Yang, D V Devine, B M McManus.   

Abstract

Innate immunity is central to the clearance of pathogens from hosts as well as to the definition of acquired immune responses (D. T. Fearon, and R. M. Locksley, Science 272:50-53, 1996). Coxsackievirus B3 (CVB3), a human cardiopathic virus, was evaluated for the ability to activate the alternative and classical pathway of complement. CVB3 proteins interact with complement component 3 (C3, a soluble protein effector of innate immunity) after either in vitro exposure to mouse serum or in vivo murine infection and activate the alternative pathway of complement. In addition, we demonstrate that viral antigen retention and localization in germinal centers is dependent on C3, while virus antigen retention in extrafollicular regions in the spleen is not. In vivo depletion of native C3 abolished the rapid formation of virus-specific germinal centers (by day 3 post-CVB3 infection) in the absence of serum anti-CVB3 antibodies. These studies demonstrate that innate immune mechanisms, such as C3 interaction with CVB3, are essential for splenic antiviral germinal center formation in naive (antigen nonsensitized) mice resistant (C57BL/6J strain) and susceptible (A/J strain) to CVB3-induced myocarditis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343244      PMCID: PMC192350     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

Review 1.  Follicular dendritic cells as accessory cells.

Authors:  J G Tew; M H Kosco; G F Burton; A K Szakal
Journal:  Immunol Rev       Date:  1990-10       Impact factor: 12.988

2.  Antigen processing and presentation in vivo: the microenvironment as a crucial factor.

Authors:  N van Rooijen
Journal:  Immunol Today       Date:  1990-12

Review 3.  Complement evasion strategies of microorganisms.

Authors:  N R Cooper
Journal:  Immunol Today       Date:  1991-09

4.  Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens.

Authors:  Y J Liu; J Zhang; P J Lane; E Y Chan; I C MacLennan
Journal:  Eur J Immunol       Date:  1991-12       Impact factor: 5.532

Review 5.  The alternative antigen pathway.

Authors:  J G Tew; M H Kosco; A K Szakal
Journal:  Immunol Today       Date:  1989-07

6.  A novel in vivo follicular dendritic cell-dependent iccosome-mediated mechanism for delivery of antigen to antigen-processing cells.

Authors:  A K Szakal; M H Kosco; J G Tew
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

7.  Germinal center B cells present antigen obtained in vivo to T cells in vitro and stimulate mixed lymphocyte reactions.

Authors:  M H Kosco; A P Monfalcone; A K Szakal; J G Tew
Journal:  Adv Exp Med Biol       Date:  1988       Impact factor: 2.622

8.  HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses.

Authors:  R P Tomko; R Xu; L Philipson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

9.  Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms.

Authors:  P A Lodge; M Herzum; J Olszewski; S A Huber
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

10.  Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion.

Authors:  V Boyer; C Desgranges; M A Trabaud; E Fischer; M D Kazatchkine
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

2.  Comparative and correlative assessments of cytokine, complement and antibody patterns in paediatric type 1 diabetes.

Authors:  M Abdel-Latif; A A Abdel-Moneim; M H El-Hefnawy; R G Khalil
Journal:  Clin Exp Immunol       Date:  2017-07-13       Impact factor: 4.330

3.  The role of B lymphocytes in coxsackievirus B3 infection.

Authors:  I Mena; C M Perry; S Harkins; F Rodriguez; J Gebhard; J L Whitton
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

4.  Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes.

Authors:  Thomas P Zwaka; Dimitar Manolov; Cüneyt Ozdemir; Nikolaus Marx; Ziya Kaya; Matthias Kochs; Martin Höher; Vinzenz Hombach; Jan Torzewski
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 5.  Herpes simplex virus as a tool to define the role of complement in the immune response to peripheral infection.

Authors:  Mark A Brockman; David M Knipe
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

6.  A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor.

Authors:  Shaofu Qiu; Nan Liu; Leili Jia; Guang Yang; Wenli Su; Jing Li; Lixue Song; Chaojie Yang; Jian Wang; Chuanfu Zhang; Zhongqiang Wang; Fei Qiao; Stephen Tomlinson; Carl Atkinson; Yansong Sun; Liuyu Huang; Hongbin Song; Yong Wang; Zhenjun Li
Journal:  Virol J       Date:  2012-11-23       Impact factor: 4.099

Review 7.  Complement Evasion Strategies of Viruses: An Overview.

Authors:  Palak Agrawal; Renuka Nawadkar; Hina Ojha; Jitendra Kumar; Arvind Sahu
Journal:  Front Microbiol       Date:  2017-06-16       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.